NCT00715182
- Conditions
- Adenocarcinoma, Advanced/ Metastatic Renal Cell Cancer, Carcinoma, +14 more
- Locations
-
- Novartis Investigative Site San Francisco, California, United States
- Novartis Investigative Site Durham, North Carolina, United States
- Novartis Investigative Site Seattle, Washington, United States
- Novartis Investigative Site Bordeaux, France